Inflammation and its resolution in atherosclerosis: mediators and therapeutic opportunities.


Journal

Nature reviews. Cardiology
ISSN: 1759-5010
Titre abrégé: Nat Rev Cardiol
Pays: England
ID NLM: 101500075

Informations de publication

Date de publication:
07 2019
Historique:
pubmed: 9 3 2019
medline: 21 1 2020
entrez: 9 3 2019
Statut: ppublish

Résumé

Atherosclerosis is a lipid-driven inflammatory disease of the arterial intima in which the balance of pro-inflammatory and inflammation-resolving mechanisms dictates the final clinical outcome. Intimal infiltration and modification of plasma-derived lipoproteins and their uptake mainly by macrophages, with ensuing formation of lipid-filled foam cells, initiate atherosclerotic lesion formation, and deficient efferocytotic removal of apoptotic cells and foam cells sustains lesion progression. Defective efferocytosis, as a sign of inadequate inflammation resolution, leads to accumulation of secondarily necrotic macrophages and foam cells and the formation of an advanced lesion with a necrotic lipid core, indicative of plaque vulnerability. Resolution of inflammation is mediated by specialized pro-resolving lipid mediators derived from omega-3 fatty acids or arachidonic acid and by relevant proteins and signalling gaseous molecules. One of the major effects of inflammation resolution mediators is phenotypic conversion of pro-inflammatory macrophages into macrophages that suppress inflammation and promote healing. In advanced atherosclerotic lesions, the ratio between specialized pro-resolving mediators and pro-inflammatory lipids (in particular leukotrienes) is strikingly low, providing a molecular explanation for the defective inflammation resolution features of these lesions. In this Review, we discuss the mechanisms of the formation of clinically dangerous atherosclerotic lesions and the potential of pro-resolving mediator therapy to inhibit this process.

Identifiants

pubmed: 30846875
doi: 10.1038/s41569-019-0169-2
pii: 10.1038/s41569-019-0169-2
pmc: PMC6727648
mid: NIHMS1048780
doi:

Substances chimiques

Inflammasomes 0
Lipoproteins 0
NLR Family, Pyrin Domain-Containing 3 Protein 0
NLRP3 protein, human 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

389-406

Subventions

Organisme : NHLBI NIH HHS
ID : R35 HL145228
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL107497
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL140554
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL132412
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL127464
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL075662
Pays : United States
Organisme : NHLBI NIH HHS
ID : K99 HL145131
Pays : United States
Organisme : NHLBI NIH HHS
ID : T32 HL007343
Pays : United States
Organisme : NHLBI NIH HHS
ID : P01 HL087123
Pays : United States

Références

Nature. 2014 Jun 5;510(7503):92-101
pubmed: 24899309
Dev Cell. 2016 Jul 25;38(2):147-60
pubmed: 27459067
J Cell Biol. 2008 Mar 10;180(5):989-1003
pubmed: 18332220
Nat Immunol. 2016 Feb;17(2):159-68
pubmed: 26642357
FASEB J. 2007 Feb;21(2):325-32
pubmed: 17267386
Proc Natl Acad Sci U S A. 2012 Sep 11;109(37):14983-8
pubmed: 22927428
Eur J Immunol. 2011 Sep;41(9):2515-8
pubmed: 21952808
Am J Pathol. 2010 Oct;177(4):2116-23
pubmed: 20709806
Nat Med. 2011 Nov 07;17(11):1410-22
pubmed: 22064431
Curr Opin Lipidol. 2016 Oct;27(5):493-8
pubmed: 27472410
Immunity. 2013 Apr 18;38(4):792-804
pubmed: 23601688
Arterioscler Thromb Vasc Biol. 2018 Aug;38(8):1702-1710
pubmed: 29903736
J Immunol. 2005 Mar 1;174(5):3015-23
pubmed: 15728515
Hypertension. 2015 Sep;66(3):657-66
pubmed: 26150435
Circ Res. 2016 Feb 19;118(4):679-91
pubmed: 26892966
Histochem Cell Biol. 2006 Aug;126(2):149-58
pubmed: 16816938
Proc Natl Acad Sci U S A. 2006 Jul 5;103(27):10340-10345
pubmed: 16801531
J Biol Chem. 2013 Dec 13;288(50):35812-23
pubmed: 24189069
Biochim Biophys Acta. 2015 Nov;1851(11):1442-9
pubmed: 26327597
JAMA Cardiol. 2018 Mar 1;3(3):225-234
pubmed: 29387889
Semin Immunol. 2015 May;27(3):227-33
pubmed: 26095908
Transl Res. 2009 Apr;153(4):166-76
pubmed: 19304275
Sci Signal. 2018 Sep 25;11(549):
pubmed: 30254055
J Exp Med. 2014 Jun 2;211(6):1037-48
pubmed: 24863066
Am J Pathol. 2017 Jun;187(6):1211-1221
pubmed: 28527709
J Biol Chem. 2011 Sep 23;286(38):33335-44
pubmed: 21828049
Science. 2007 Jun 8;316(5830):1488-91
pubmed: 17478681
Trends Pharmacol Sci. 2015 Nov;36(11):737-755
pubmed: 26478210
J Intern Med. 2010 Oct;268(4):320-8
pubmed: 21050286
Arterioscler Thromb Vasc Biol. 2016 Sep;36(9):1937-46
pubmed: 27417584
Arterioscler Thromb Vasc Biol. 2018 Jan;38(1):218-231
pubmed: 29074585
Eur Heart J. 2018 Jul 14;39(27):2562-2573
pubmed: 29982602
Curr Opin Lipidol. 2011 Oct;22(5):335-42
pubmed: 21841486
Oncogene. 2011 Sep 8;30(36):3887-99
pubmed: 21499310
EMBO Mol Med. 2012 Oct;4(10):1072-86
pubmed: 23027612
Circ Res. 2018 Jun 8;122(12):1661-1674
pubmed: 29545365
Sci Rep. 2012;2:499
pubmed: 22787557
Arterioscler Thromb Vasc Biol. 2017 Feb;37(2):312-315
pubmed: 28062503
Atherosclerosis. 1997 Apr;130(1-2):17-27
pubmed: 9126644
Circ Res. 2017 Feb 17;120(4):736-743
pubmed: 28209798
J Immunol. 2011 Nov 15;187(10):5408-18
pubmed: 22013115
Atherosclerosis. 2018 Aug;275:376-378
pubmed: 29843914
Circ Res. 2018 Jun 8;122(12):1722-1740
pubmed: 29880500
Curr Opin Lipidol. 1998 Oct;9(5):471-4
pubmed: 9812202
Cell. 2011 Dec 23;147(7):1442-5
pubmed: 22196723
J Immunol. 2017 Mar 1;198(5):2105-2114
pubmed: 28130494
Immunity. 2018 Oct 16;49(4):666-677.e6
pubmed: 30291029
Clin Cardiol. 2017 Mar;40(3):138-148
pubmed: 28294373
Immunol Rev. 2014 Nov;262(1):153-66
pubmed: 25319333
Arterioscler Thromb Vasc Biol. 1995 May;15(5):551-61
pubmed: 7749869
FASEB J. 2008 Oct;22(10):3595-606
pubmed: 18559988
Sci Adv. 2016 Jul 22;2(7):e1600224
pubmed: 27532042
Trends Cardiovasc Med. 2018 Jul;28(5):348-354
pubmed: 29336946
FASEB J. 2016 Dec;30(12):4192-4201
pubmed: 27619672
Cardiovasc Res. 2008 Apr 1;78(1):175-84
pubmed: 18192240
J Biol Chem. 1997 May 23;272(21):13597-607
pubmed: 9153208
Biochem Biophys Res Commun. 2005 Dec 9;338(1):102-10
pubmed: 16122704
PLoS One. 2010 Jul 23;5(7):e11765
pubmed: 20668705
Circulation. 2013 Jun 25;127(25):2523-34
pubmed: 23704252
Arterioscler Thromb Vasc Biol. 2009 Feb;29(2):173-9
pubmed: 18988885
Arterioscler Thromb Vasc Biol. 2012 Mar;32(3):595-604
pubmed: 22267481
J Clin Invest. 2017 Feb 1;127(2):564-568
pubmed: 28067670
Arterioscler Thromb. 1991 May-Jun;11(3):569-77
pubmed: 2029497
Antioxid Redox Signal. 2009 Sep;11(9):2333-9
pubmed: 19243235
J Immunol. 2015 Mar 1;194(5):2330-7
pubmed: 25637017
Annu Rev Immunol. 2009;27:165-97
pubmed: 19302038
Arterioscler Thromb Vasc Biol. 2002 Nov 1;22(11):1892-8
pubmed: 12426221
J Leukoc Biol. 2019 Jan;105(1):25-36
pubmed: 29601102
Gastroenterology. 2009 Aug;137(2):569-78, 578.e1
pubmed: 19375422
Nat Immunol. 2012 Jan 08;13(2):136-43
pubmed: 22231519
Circ Res. 2016 Jan 22;118(2):230-40
pubmed: 26596284
J Immunol. 2013 Jun 15;190(12):6378-88
pubmed: 23650615
Atherosclerosis. 2018 Nov;278:259-268
pubmed: 30340110
Nat Immunol. 2011 May;12(5):408-15
pubmed: 21478880
Circ Res. 2017 May 26;120(11):1789-1799
pubmed: 28302649
Nature. 2009 Oct 29;461(7268):1287-91
pubmed: 19865173
Circ Res. 2016 Feb 19;118(4):692-702
pubmed: 26892967
Curr Opin Lipidol. 2017 Apr;28(2):91-98
pubmed: 28134664
Nat Rev Immunol. 2009 Jan;9(1):62-70
pubmed: 19104500
Am J Pathol. 2012 May;180(5):2018-27
pubmed: 22449948
Nat Rev Immunol. 2008 Dec;8(12):958-69
pubmed: 19029990
Sci Transl Med. 2015 Feb 18;7(275):275ra20
pubmed: 25695999
Arterioscler Thromb Vasc Biol. 2008 Aug;28(8):1429-31
pubmed: 18467644
N Engl J Med. 2018 Oct 18;379(16):1540-1550
pubmed: 30146932
Prostaglandins Leukot Essent Fatty Acids. 2017 Feb;117:17-27
pubmed: 28237084
Sci Rep. 2017 Nov 16;7(1):15724
pubmed: 29146976
Am J Pathol. 2010 Oct;177(4):1576-91
pubmed: 20813960
J Clin Invest. 1997 Dec 1;100(11):2680-90
pubmed: 9389731
Trends Biochem Sci. 2016 Dec;41(12):1012-1021
pubmed: 27669650
Nature. 2002 Jun 13;417(6890):750-4
pubmed: 12066187
FASEB J. 2018 Oct;32(10):5413-5425
pubmed: 29723062
Cell Adh Migr. 2017 May 4;11(3):261-274
pubmed: 27860536
BMC Cardiovasc Disord. 2014 Apr 30;14:56
pubmed: 24779513
Arterioscler Thromb Vasc Biol. 2010 Apr;30(4):787-95
pubmed: 20150557
Nature. 2016 Aug 4;536(7614):86-90
pubmed: 27437576
Atherosclerosis. 1990 Oct;84(2-3):165-71
pubmed: 2149267
JACC Basic Transl Sci. 2018 Dec 31;3(6):719-727
pubmed: 30623131
Circulation. 2014 Apr 15;129(15):1551-9
pubmed: 24481950
J Lipid Res. 2015 Feb;56(2):203-14
pubmed: 25424004
Oncotarget. 2016 Nov 8;7(45):73229-73241
pubmed: 27689324
Arterioscler Thromb Vasc Biol. 1995 Apr;15(4):534-42
pubmed: 7749867
Circ Res. 2011 Apr 15;108(8):985-95
pubmed: 21350215
Nat Rev Cardiol. 2015 Nov;12(11):643-58
pubmed: 26259935
Curr Opin Lipidol. 2012 Oct;23(5):429-38
pubmed: 22964992
Cardiovasc Res. 2015 Jan 1;105(1):65-74
pubmed: 25341894
Nat Rev Immunol. 2010 Jan;10(1):36-46
pubmed: 19960040
Circulation. 2007 Oct 16;116(16):1832-44
pubmed: 17938300
Immunol Rev. 2016 Jan;269(1):44-59
pubmed: 26683144
Biochemistry. 2004 Feb 17;43(6):1685-93
pubmed: 14769046
Arterioscler Thromb Vasc Biol. 2015 Apr;35(4):763-70
pubmed: 25675999
Circulation. 2001 Feb 20;103(7):926-33
pubmed: 11181465
Cell. 2010 Mar 5;140(5):619-30
pubmed: 20211132
Circ Res. 2016 Feb 19;118(4):668-78
pubmed: 26892965
J Leukoc Biol. 2009 Nov;86(5):1089-95
pubmed: 19414539
Nat Med. 2013 Sep;19(9):1166-72
pubmed: 23933982
Arterioscler Thromb Vasc Biol. 2015 Feb;35(2):280-7
pubmed: 25414253
Front Cardiovasc Med. 2018 Jan 08;4:86
pubmed: 29379788
Circ Res. 2016 Feb 19;118(4):653-67
pubmed: 26892964
Nature. 2012 Apr 25;484(7395):524-8
pubmed: 22538616
Cell. 2010 Mar 19;140(6):871-82
pubmed: 20303877
Curr Top Med Chem. 2011;11(6):629-47
pubmed: 21261595
Trends Mol Med. 2017 Feb;23(2):165-180
pubmed: 28109721
N Engl J Med. 2009 Jun 4;360(23):2467-70
pubmed: 19494224
PLoS One. 2012;7(5):e37073
pubmed: 22590646
Coron Artery Dis. 2016 Dec;27(8):636-649
pubmed: 27388482
Eur J Pharmacol. 2015 Aug 5;760:49-63
pubmed: 25895638
Cold Spring Harb Perspect Biol. 2012 Jun 01;4(6):
pubmed: 22661635
Arterioscler Thromb Vasc Biol. 2017 Aug;37(8):1457-1461
pubmed: 28596375
Science. 2007 Jun 8;316(5830):1491-3
pubmed: 17478679
Cell Death Differ. 2016 Jun;23(6):915-26
pubmed: 26990661
Pharmacol Rev. 2018 Jan;70(1):174-196
pubmed: 29279348
Nature. 2018 Jun;558(7709):301-306
pubmed: 29875409
Eur J Pharmacol. 2017 Dec 5;816:14-24
pubmed: 28989084
Circ Res. 2016 Oct 14;119(9):1030-1038
pubmed: 27531933
J Intern Med. 2015 Nov;278(5):483-93
pubmed: 26260307
J Am Coll Cardiol. 2018 Jul 17;72(3):314-329
pubmed: 30012326
Cell Metab. 2017 Jun 6;25(6):1294-1304.e6
pubmed: 28479366
PLoS One. 2012;7(6):e39790
pubmed: 22761902
Clin Vaccine Immunol. 2013 Mar;20(3):319-27
pubmed: 23283640
Curr Opin Lipidol. 2012 Oct;23(5):412-21
pubmed: 22964991
N Engl J Med. 2017 Sep 21;377(12):1119-1131
pubmed: 28845751
Nat Med. 2002 Nov;8(11):1235-42
pubmed: 12411950
Curr Opin Lipidol. 2016 Oct;27(5):473-83
pubmed: 27472409
Arterioscler Thromb Vasc Biol. 2008 Aug;28(8):1421-8
pubmed: 18451332
Circulation. 2018 Aug 28;138(9):898-912
pubmed: 29588315
FASEB J. 2015 Jun;29(6):2504-13
pubmed: 25777995
J Immunol. 2015 Feb 1;194(3):863-7
pubmed: 25539814
Circ Cardiovasc Genet. 2012 Feb 1;5(1):122-31
pubmed: 22238190
Nat Commun. 2016 Sep 23;7:12859
pubmed: 27659679
Circulation. 2017 Jan 31;135(5):476-489
pubmed: 28137963
Mucosal Immunol. 2016 May;9(3):757-766
pubmed: 26462421
J Lipid Res. 2015 Sep;56(9):1808-20
pubmed: 26180051
Proc Natl Acad Sci U S A. 2016 Jun 7;113(23):6526-31
pubmed: 27199481
J Leukoc Biol. 2016 Sep;100(3):481-9
pubmed: 27354413
Arterioscler Thromb Vasc Biol. 2016 Mar;36(3):456-65
pubmed: 26821944
Science. 2010 Jan 15;327(5963):296-300
pubmed: 20075245
FASEB J. 2013 Jun;27(6):2220-32
pubmed: 23407709
J Lipid Res. 2000 Nov;41(11):1703-14
pubmed: 11060340
Nat Immunol. 2013 Aug;14(8):812-20
pubmed: 23812099
N Engl J Med. 2005 Apr 21;352(16):1685-95
pubmed: 15843671
Br J Pharmacol. 2017 Nov;174(22):4043-4054
pubmed: 28071789
J Lipid Res. 2015 Aug;56(8):1449-60
pubmed: 26059978
J Leukoc Biol. 2010 Oct;88(4):769-78
pubmed: 20610799
J Immunol. 2000 Feb 15;164(4):1663-7
pubmed: 10657608
Proc Natl Acad Sci U S A. 2014 Oct 7;111(40):14530-5
pubmed: 25246560
Circ Res. 2010 Feb 5;106(2):383-90
pubmed: 19893012
Microbiol Spectr. 2016 Jun;4(3):
pubmed: 27337457
Circ Res. 2018 Jun 8;122(12):1675-1688
pubmed: 29545366
Circulation. 2018 Oct 16;138(16):1736-1748
pubmed: 30354461
Br J Pharmacol. 2019 Apr;176(8):1024-1037
pubmed: 29679485
Proc Natl Acad Sci U S A. 1990 Jun;87(12):4600-4
pubmed: 1972277
Cell Metab. 2011 Jun 8;13(6):655-67
pubmed: 21641547
Nat Commun. 2014;5:3147
pubmed: 24445679
J Exp Med. 2017 Jul 3;214(7):1913-1923
pubmed: 28606987
Heart. 2004 Dec;90(12):1385-91
pubmed: 15547008
J Biol Chem. 2010 Jan 29;285(5):3451-61
pubmed: 19906641
J Am Heart Assoc. 2015 Apr 06;4(4):
pubmed: 25845931
Arterioscler Thromb Vasc Biol. 2015 May;35(5):1123-33
pubmed: 25792445
N Engl J Med. 2019 Jan 3;380(1):11-22
pubmed: 30415628
Autophagy. 2015;11(10):1729-44
pubmed: 26506892
Am J Pathol. 2018 Feb;188(2):525-538
pubmed: 29154769
Arterioscler Thromb Vasc Biol. 2005 Mar;25(3):e17-8
pubmed: 15662025
Annu Rev Biochem. 1983;52:223-61
pubmed: 6311077
J Clin Invest. 2018 Jul 2;128(7):2713-2723
pubmed: 30108191
Circ Res. 2010 Oct 1;107(7):839-50
pubmed: 20884885
Arterioscler Thromb Vasc Biol. 2015 Mar;35(3):535-46
pubmed: 25573853
Circulation. 2002 Mar 5;105(9):1135-43
pubmed: 11877368
J Intern Med. 2000 Mar;247(3):359-70
pubmed: 10762453
Science. 2013 Jan 11;339(6116):166-72
pubmed: 23307734
FASEB J. 2016 Aug;30(8):2792-801
pubmed: 27121596
Circ Res. 2017 Oct 27;121(10):1119-1121
pubmed: 29074528
Atherosclerosis. 2016 May;248:170-8
pubmed: 27038418
Pharmacol Ther. 2018 Aug;188:12-25
pubmed: 29444453
Curr Opin Lipidol. 2018 Oct;29(5):389-396
pubmed: 30020199
Br J Pharmacol. 2014 Aug;171(15):3551-74
pubmed: 24588652
Circ Res. 2007 Mar 16;100(5):670-7
pubmed: 17303763
J Am Heart Assoc. 2016 Sep 13;5(9):
pubmed: 27625345
J Immunol. 2018 Feb 1;200(3):1169-1187
pubmed: 29263216
Int J Cardiol. 2015 Jan 20;179:370-2
pubmed: 25464488
J Cell Sci. 2014 May 15;127(Pt 10):2135-44
pubmed: 24833670
J Biol Chem. 1980 Oct 10;255(19):9344-52
pubmed: 7410428
Proc Natl Acad Sci U S A. 2000 May 9;97(10):5261-6
pubmed: 10779545
Prog Lipid Res. 2018 Jan;69:21-32
pubmed: 29269048
Immunity. 2017 Oct 17;47(4):697-709.e3
pubmed: 29045901
Front Immunol. 2014 Oct 17;5:514
pubmed: 25368618
Circ Res. 2015 Feb 27;116(5):827-35
pubmed: 25520364
J Am Soc Nephrol. 2002 Oct;13(10):2497-507
pubmed: 12239238
Arterioscler Thromb Vasc Biol. 2009 Oct;29(10):1412-8
pubmed: 19759373
Clin Sci (Lond). 2013 Aug;125(3):121-30
pubmed: 23577635
Circulation. 2018 Oct 16;138(16):1693-1705
pubmed: 29739755
Biochem J. 2016 May 15;473(10):1281-95
pubmed: 27208212
Am J Physiol Heart Circ Physiol. 2015 Sep;309(5):H1017-28
pubmed: 26254337
Methods Mol Biol. 2013;1040:19-27
pubmed: 23852594
Thromb Haemost. 2015 Mar;113(3):505-12
pubmed: 25373619
J Clin Invest. 2014 Mar;124(3):1083-97
pubmed: 24531546
Eur J Prev Cardiol. 2017 Jun;24(9):903-906
pubmed: 28195518
Am J Physiol Cell Physiol. 2016 Oct 1;311(4):C537-C543
pubmed: 27385721
Atherosclerosis. 2016 Jul;250:158-65
pubmed: 27236706
Circ Res. 2018 Oct 26;123(10):1127-1142
pubmed: 30359200

Auteurs

Magnus Bäck (M)

Department of Cardiology, Karolinska University Hospital, Stockholm, Sweden.

Arif Yurdagul (A)

Columbia University Irving Medical Center, New York, NY, USA.

Ira Tabas (I)

Columbia University Irving Medical Center, New York, NY, USA.

Katariina Öörni (K)

Atherosclerosis Research Laboratory, Wihuri Research Institute, Helsinki, Finland.
Molecular and Integrative Biosciences Research Programme, Faculty of Biological and Environmental Sciences, University of Helsinki, Helsinki, Finland.

Petri T Kovanen (PT)

Atherosclerosis Research Laboratory, Wihuri Research Institute, Helsinki, Finland. petri.kovanen@wri.fi.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH